Pfizer Receives FDA Approval for RSV Vaccine
- Posted on October 22, 2024
- By Bing News
- 1 Views
Pfizer Receives FDA Approval for RSV Vaccine
Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at increased risk. It is the first RSV vaccine indicated for adults younger than 50, Pfizer said.
